PHARMACOLOGY & THERAPEUTICS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=959640, encodeId=3fa195964008, content=先给编辑写询问信，编辑同意投稿发出约稿申请，给一个月时间写作，然后2月28日投出去，一个月左右给初审意见大修，然后痛苦修改一个月后，4月21日投出去，4月22日直接编辑接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0fda5217760, createdName=14772c6cm60暂无昵称, createdTime=Fri Apr 23 00:27:32 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140450, encodeId=f718214045047, content=审稿速度:3.0 经验分享：话说这是药学的顶级综述期刊。。。2022.12月投稿，2023.4月大修，2023.5中旬修回后一周接受并online。前期找审稿人花费了不少时间，后面进行的非常快！点赞👍祝期刊越来越好～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Fri Jun 02 09:44:23 CST 2023, time=2023-06-02, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2110794, encodeId=d86f2110e9401, content=Underreview 快俩月了，Status date变化好几次了是啥意思呢？？？？有投过的老哥交流一下嘛？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Jan 18 22:47:43 CST 2023, time=2023-01-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2198821, encodeId=cd84219882131, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：药理 经验分享：困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25d46161544, createdName=ms2000001453861010, createdTime=Tue Apr 16 15:26:25 CST 2024, time=2024-04-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176210, encodeId=dee821e62105f, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：首次决定时间很长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13586411720, createdName=ms4000000644047431, createdTime=Thu Dec 21 00:04:24 CST 2023, time=2023-12-21, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1096295, encodeId=e71e10962954a, content=我为什么投了一个月/很长时间都没有消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974654, encodeId=b3749e4654ff, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：目前该杂志需要接受约稿，自己投不行的，本人通过约稿于2020年4月接受了一篇，前后花费大半年时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a24f4cfbb98ea468e1e28fabfa0347c5.jpg, createdBy=92c81626055, createdName=xinshihaoran, createdTime=Fri Jun 18 14:24:44 CST 2021, time=2021-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241093, encodeId=2d121241093a4, content=审稿周期多久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e7a5327063, createdName=148bf3b8m15暂无昵称, createdTime=Fri Aug 26 09:29:34 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096296, encodeId=96b8109629693, content=期刊的审稿时间一般是多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553240, encodeId=4856553240fc, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：杂志学术水平较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=570, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1de937989, createdName=z8160720, createdTime=Sat Mar 03 18:10:00 CST 2018, time=2018-03-03, status=1, ipAttribution=)]

2021-04-23 14772c6cm60暂无昵称

先给编辑写询问信，编辑同意投稿发出约稿申请，给一个月时间写作，然后2月28日投出去，一个月左右给初审意见大修，然后痛苦修改一个月后，4月21日投出去，4月22日直接编辑接受。

284 11 举报

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=959640, encodeId=3fa195964008, content=先给编辑写询问信，编辑同意投稿发出约稿申请，给一个月时间写作，然后2月28日投出去，一个月左右给初审意见大修，然后痛苦修改一个月后，4月21日投出去，4月22日直接编辑接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0fda5217760, createdName=14772c6cm60暂无昵称, createdTime=Fri Apr 23 00:27:32 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140450, encodeId=f718214045047, content=审稿速度:3.0 经验分享：话说这是药学的顶级综述期刊。。。2022.12月投稿，2023.4月大修，2023.5中旬修回后一周接受并online。前期找审稿人花费了不少时间，后面进行的非常快！点赞👍祝期刊越来越好～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Fri Jun 02 09:44:23 CST 2023, time=2023-06-02, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2110794, encodeId=d86f2110e9401, content=Underreview 快俩月了，Status date变化好几次了是啥意思呢？？？？有投过的老哥交流一下嘛？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Jan 18 22:47:43 CST 2023, time=2023-01-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2198821, encodeId=cd84219882131, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：药理 经验分享：困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25d46161544, createdName=ms2000001453861010, createdTime=Tue Apr 16 15:26:25 CST 2024, time=2024-04-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176210, encodeId=dee821e62105f, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：首次决定时间很长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13586411720, createdName=ms4000000644047431, createdTime=Thu Dec 21 00:04:24 CST 2023, time=2023-12-21, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1096295, encodeId=e71e10962954a, content=我为什么投了一个月/很长时间都没有消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974654, encodeId=b3749e4654ff, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：目前该杂志需要接受约稿，自己投不行的，本人通过约稿于2020年4月接受了一篇，前后花费大半年时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a24f4cfbb98ea468e1e28fabfa0347c5.jpg, createdBy=92c81626055, createdName=xinshihaoran, createdTime=Fri Jun 18 14:24:44 CST 2021, time=2021-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241093, encodeId=2d121241093a4, content=审稿周期多久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e7a5327063, createdName=148bf3b8m15暂无昵称, createdTime=Fri Aug 26 09:29:34 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096296, encodeId=96b8109629693, content=期刊的审稿时间一般是多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553240, encodeId=4856553240fc, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：杂志学术水平较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=570, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1de937989, createdName=z8160720, createdTime=Sat Mar 03 18:10:00 CST 2018, time=2018-03-03, status=1, ipAttribution=)]

2023-06-02 a201061519 来自河南省

审稿速度:3.0
经验分享：话说这是药学的顶级综述期刊。。。2022.12月投稿，2023.4月大修，2023.5中旬修回后一周接受并online。前期找审稿人花费了不少时间，后面进行的非常快！点赞👍祝期刊越来越好～

159 6 举报

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=959640, encodeId=3fa195964008, content=先给编辑写询问信，编辑同意投稿发出约稿申请，给一个月时间写作，然后2月28日投出去，一个月左右给初审意见大修，然后痛苦修改一个月后，4月21日投出去，4月22日直接编辑接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0fda5217760, createdName=14772c6cm60暂无昵称, createdTime=Fri Apr 23 00:27:32 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140450, encodeId=f718214045047, content=审稿速度:3.0 经验分享：话说这是药学的顶级综述期刊。。。2022.12月投稿，2023.4月大修，2023.5中旬修回后一周接受并online。前期找审稿人花费了不少时间，后面进行的非常快！点赞👍祝期刊越来越好～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Fri Jun 02 09:44:23 CST 2023, time=2023-06-02, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2110794, encodeId=d86f2110e9401, content=Underreview 快俩月了，Status date变化好几次了是啥意思呢？？？？有投过的老哥交流一下嘛？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Jan 18 22:47:43 CST 2023, time=2023-01-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2198821, encodeId=cd84219882131, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：药理 经验分享：困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25d46161544, createdName=ms2000001453861010, createdTime=Tue Apr 16 15:26:25 CST 2024, time=2024-04-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176210, encodeId=dee821e62105f, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：首次决定时间很长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13586411720, createdName=ms4000000644047431, createdTime=Thu Dec 21 00:04:24 CST 2023, time=2023-12-21, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1096295, encodeId=e71e10962954a, content=我为什么投了一个月/很长时间都没有消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974654, encodeId=b3749e4654ff, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：目前该杂志需要接受约稿，自己投不行的，本人通过约稿于2020年4月接受了一篇，前后花费大半年时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a24f4cfbb98ea468e1e28fabfa0347c5.jpg, createdBy=92c81626055, createdName=xinshihaoran, createdTime=Fri Jun 18 14:24:44 CST 2021, time=2021-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241093, encodeId=2d121241093a4, content=审稿周期多久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e7a5327063, createdName=148bf3b8m15暂无昵称, createdTime=Fri Aug 26 09:29:34 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096296, encodeId=96b8109629693, content=期刊的审稿时间一般是多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553240, encodeId=4856553240fc, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：杂志学术水平较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=570, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1de937989, createdName=z8160720, createdTime=Sat Mar 03 18:10:00 CST 2018, time=2018-03-03, status=1, ipAttribution=)]

2023-01-18 a201061519 来自河南省

Underreview 快俩月了，Status date变化好几次了是啥意思呢？？？？有投过的老哥交流一下嘛？？？？

170 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=959640, encodeId=3fa195964008, content=先给编辑写询问信，编辑同意投稿发出约稿申请，给一个月时间写作，然后2月28日投出去，一个月左右给初审意见大修，然后痛苦修改一个月后，4月21日投出去，4月22日直接编辑接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0fda5217760, createdName=14772c6cm60暂无昵称, createdTime=Fri Apr 23 00:27:32 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140450, encodeId=f718214045047, content=审稿速度:3.0 经验分享：话说这是药学的顶级综述期刊。。。2022.12月投稿，2023.4月大修，2023.5中旬修回后一周接受并online。前期找审稿人花费了不少时间，后面进行的非常快！点赞👍祝期刊越来越好～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Fri Jun 02 09:44:23 CST 2023, time=2023-06-02, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2110794, encodeId=d86f2110e9401, content=Underreview 快俩月了，Status date变化好几次了是啥意思呢？？？？有投过的老哥交流一下嘛？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Jan 18 22:47:43 CST 2023, time=2023-01-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2198821, encodeId=cd84219882131, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：药理 经验分享：困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25d46161544, createdName=ms2000001453861010, createdTime=Tue Apr 16 15:26:25 CST 2024, time=2024-04-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176210, encodeId=dee821e62105f, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：首次决定时间很长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13586411720, createdName=ms4000000644047431, createdTime=Thu Dec 21 00:04:24 CST 2023, time=2023-12-21, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1096295, encodeId=e71e10962954a, content=我为什么投了一个月/很长时间都没有消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974654, encodeId=b3749e4654ff, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：目前该杂志需要接受约稿，自己投不行的，本人通过约稿于2020年4月接受了一篇，前后花费大半年时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a24f4cfbb98ea468e1e28fabfa0347c5.jpg, createdBy=92c81626055, createdName=xinshihaoran, createdTime=Fri Jun 18 14:24:44 CST 2021, time=2021-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241093, encodeId=2d121241093a4, content=审稿周期多久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e7a5327063, createdName=148bf3b8m15暂无昵称, createdTime=Fri Aug 26 09:29:34 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096296, encodeId=96b8109629693, content=期刊的审稿时间一般是多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553240, encodeId=4856553240fc, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：杂志学术水平较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=570, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1de937989, createdName=z8160720, createdTime=Sat Mar 03 18:10:00 CST 2018, time=2018-03-03, status=1, ipAttribution=)]

2024-04-16 ms2000001453861010 来自浙江省

审稿速度:12.0 | 投稿命中率:25.0
偏重的研究方向：药理
经验分享：困难

153 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=959640, encodeId=3fa195964008, content=先给编辑写询问信，编辑同意投稿发出约稿申请，给一个月时间写作，然后2月28日投出去，一个月左右给初审意见大修，然后痛苦修改一个月后，4月21日投出去，4月22日直接编辑接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0fda5217760, createdName=14772c6cm60暂无昵称, createdTime=Fri Apr 23 00:27:32 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140450, encodeId=f718214045047, content=审稿速度:3.0 经验分享：话说这是药学的顶级综述期刊。。。2022.12月投稿，2023.4月大修，2023.5中旬修回后一周接受并online。前期找审稿人花费了不少时间，后面进行的非常快！点赞👍祝期刊越来越好～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Fri Jun 02 09:44:23 CST 2023, time=2023-06-02, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2110794, encodeId=d86f2110e9401, content=Underreview 快俩月了，Status date变化好几次了是啥意思呢？？？？有投过的老哥交流一下嘛？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Jan 18 22:47:43 CST 2023, time=2023-01-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2198821, encodeId=cd84219882131, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：药理 经验分享：困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25d46161544, createdName=ms2000001453861010, createdTime=Tue Apr 16 15:26:25 CST 2024, time=2024-04-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176210, encodeId=dee821e62105f, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：首次决定时间很长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13586411720, createdName=ms4000000644047431, createdTime=Thu Dec 21 00:04:24 CST 2023, time=2023-12-21, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1096295, encodeId=e71e10962954a, content=我为什么投了一个月/很长时间都没有消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974654, encodeId=b3749e4654ff, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：目前该杂志需要接受约稿，自己投不行的，本人通过约稿于2020年4月接受了一篇，前后花费大半年时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a24f4cfbb98ea468e1e28fabfa0347c5.jpg, createdBy=92c81626055, createdName=xinshihaoran, createdTime=Fri Jun 18 14:24:44 CST 2021, time=2021-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241093, encodeId=2d121241093a4, content=审稿周期多久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e7a5327063, createdName=148bf3b8m15暂无昵称, createdTime=Fri Aug 26 09:29:34 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096296, encodeId=96b8109629693, content=期刊的审稿时间一般是多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553240, encodeId=4856553240fc, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：杂志学术水平较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=570, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1de937989, createdName=z8160720, createdTime=Sat Mar 03 18:10:00 CST 2018, time=2018-03-03, status=1, ipAttribution=)]

2023-12-21 ms4000000644047431 来自湖北省

审稿速度:3.0 | 投稿命中率:25.0
经验分享：首次决定时间很长

156 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=959640, encodeId=3fa195964008, content=先给编辑写询问信，编辑同意投稿发出约稿申请，给一个月时间写作，然后2月28日投出去，一个月左右给初审意见大修，然后痛苦修改一个月后，4月21日投出去，4月22日直接编辑接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0fda5217760, createdName=14772c6cm60暂无昵称, createdTime=Fri Apr 23 00:27:32 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140450, encodeId=f718214045047, content=审稿速度:3.0 经验分享：话说这是药学的顶级综述期刊。。。2022.12月投稿，2023.4月大修，2023.5中旬修回后一周接受并online。前期找审稿人花费了不少时间，后面进行的非常快！点赞👍祝期刊越来越好～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Fri Jun 02 09:44:23 CST 2023, time=2023-06-02, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2110794, encodeId=d86f2110e9401, content=Underreview 快俩月了，Status date变化好几次了是啥意思呢？？？？有投过的老哥交流一下嘛？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Jan 18 22:47:43 CST 2023, time=2023-01-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2198821, encodeId=cd84219882131, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：药理 经验分享：困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25d46161544, createdName=ms2000001453861010, createdTime=Tue Apr 16 15:26:25 CST 2024, time=2024-04-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176210, encodeId=dee821e62105f, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：首次决定时间很长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13586411720, createdName=ms4000000644047431, createdTime=Thu Dec 21 00:04:24 CST 2023, time=2023-12-21, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1096295, encodeId=e71e10962954a, content=我为什么投了一个月/很长时间都没有消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974654, encodeId=b3749e4654ff, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：目前该杂志需要接受约稿，自己投不行的，本人通过约稿于2020年4月接受了一篇，前后花费大半年时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a24f4cfbb98ea468e1e28fabfa0347c5.jpg, createdBy=92c81626055, createdName=xinshihaoran, createdTime=Fri Jun 18 14:24:44 CST 2021, time=2021-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241093, encodeId=2d121241093a4, content=审稿周期多久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e7a5327063, createdName=148bf3b8m15暂无昵称, createdTime=Fri Aug 26 09:29:34 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096296, encodeId=96b8109629693, content=期刊的审稿时间一般是多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553240, encodeId=4856553240fc, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：杂志学术水平较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=570, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1de937989, createdName=z8160720, createdTime=Sat Mar 03 18:10:00 CST 2018, time=2018-03-03, status=1, ipAttribution=)]

2021-12-28 msSSSSSD

我为什么投了一个月/很长时间都没有消息？

314 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=959640, encodeId=3fa195964008, content=先给编辑写询问信，编辑同意投稿发出约稿申请，给一个月时间写作，然后2月28日投出去，一个月左右给初审意见大修，然后痛苦修改一个月后，4月21日投出去，4月22日直接编辑接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0fda5217760, createdName=14772c6cm60暂无昵称, createdTime=Fri Apr 23 00:27:32 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140450, encodeId=f718214045047, content=审稿速度:3.0 经验分享：话说这是药学的顶级综述期刊。。。2022.12月投稿，2023.4月大修，2023.5中旬修回后一周接受并online。前期找审稿人花费了不少时间，后面进行的非常快！点赞👍祝期刊越来越好～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Fri Jun 02 09:44:23 CST 2023, time=2023-06-02, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2110794, encodeId=d86f2110e9401, content=Underreview 快俩月了，Status date变化好几次了是啥意思呢？？？？有投过的老哥交流一下嘛？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Jan 18 22:47:43 CST 2023, time=2023-01-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2198821, encodeId=cd84219882131, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：药理 经验分享：困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25d46161544, createdName=ms2000001453861010, createdTime=Tue Apr 16 15:26:25 CST 2024, time=2024-04-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176210, encodeId=dee821e62105f, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：首次决定时间很长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13586411720, createdName=ms4000000644047431, createdTime=Thu Dec 21 00:04:24 CST 2023, time=2023-12-21, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1096295, encodeId=e71e10962954a, content=我为什么投了一个月/很长时间都没有消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974654, encodeId=b3749e4654ff, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：目前该杂志需要接受约稿，自己投不行的，本人通过约稿于2020年4月接受了一篇，前后花费大半年时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a24f4cfbb98ea468e1e28fabfa0347c5.jpg, createdBy=92c81626055, createdName=xinshihaoran, createdTime=Fri Jun 18 14:24:44 CST 2021, time=2021-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241093, encodeId=2d121241093a4, content=审稿周期多久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e7a5327063, createdName=148bf3b8m15暂无昵称, createdTime=Fri Aug 26 09:29:34 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096296, encodeId=96b8109629693, content=期刊的审稿时间一般是多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553240, encodeId=4856553240fc, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：杂志学术水平较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=570, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1de937989, createdName=z8160720, createdTime=Sat Mar 03 18:10:00 CST 2018, time=2018-03-03, status=1, ipAttribution=)]

2021-06-18 xinshihaoran

审稿速度:3.0 | 投稿命中率:25.0
经验分享：目前该杂志需要接受约稿，自己投不行的，本人通过约稿于2020年4月接受了一篇，前后花费大半年时间

283 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=959640, encodeId=3fa195964008, content=先给编辑写询问信，编辑同意投稿发出约稿申请，给一个月时间写作，然后2月28日投出去，一个月左右给初审意见大修，然后痛苦修改一个月后，4月21日投出去，4月22日直接编辑接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0fda5217760, createdName=14772c6cm60暂无昵称, createdTime=Fri Apr 23 00:27:32 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140450, encodeId=f718214045047, content=审稿速度:3.0 经验分享：话说这是药学的顶级综述期刊。。。2022.12月投稿，2023.4月大修，2023.5中旬修回后一周接受并online。前期找审稿人花费了不少时间，后面进行的非常快！点赞👍祝期刊越来越好～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Fri Jun 02 09:44:23 CST 2023, time=2023-06-02, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2110794, encodeId=d86f2110e9401, content=Underreview 快俩月了，Status date变化好几次了是啥意思呢？？？？有投过的老哥交流一下嘛？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Jan 18 22:47:43 CST 2023, time=2023-01-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2198821, encodeId=cd84219882131, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：药理 经验分享：困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25d46161544, createdName=ms2000001453861010, createdTime=Tue Apr 16 15:26:25 CST 2024, time=2024-04-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176210, encodeId=dee821e62105f, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：首次决定时间很长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13586411720, createdName=ms4000000644047431, createdTime=Thu Dec 21 00:04:24 CST 2023, time=2023-12-21, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1096295, encodeId=e71e10962954a, content=我为什么投了一个月/很长时间都没有消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974654, encodeId=b3749e4654ff, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：目前该杂志需要接受约稿，自己投不行的，本人通过约稿于2020年4月接受了一篇，前后花费大半年时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a24f4cfbb98ea468e1e28fabfa0347c5.jpg, createdBy=92c81626055, createdName=xinshihaoran, createdTime=Fri Jun 18 14:24:44 CST 2021, time=2021-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241093, encodeId=2d121241093a4, content=审稿周期多久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e7a5327063, createdName=148bf3b8m15暂无昵称, createdTime=Fri Aug 26 09:29:34 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096296, encodeId=96b8109629693, content=期刊的审稿时间一般是多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553240, encodeId=4856553240fc, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：杂志学术水平较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=570, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1de937989, createdName=z8160720, createdTime=Sat Mar 03 18:10:00 CST 2018, time=2018-03-03, status=1, ipAttribution=)]

2022-08-26 148bf3b8m15暂无昵称

审稿周期多久啊

167 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=959640, encodeId=3fa195964008, content=先给编辑写询问信，编辑同意投稿发出约稿申请，给一个月时间写作，然后2月28日投出去，一个月左右给初审意见大修，然后痛苦修改一个月后，4月21日投出去，4月22日直接编辑接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0fda5217760, createdName=14772c6cm60暂无昵称, createdTime=Fri Apr 23 00:27:32 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140450, encodeId=f718214045047, content=审稿速度:3.0 经验分享：话说这是药学的顶级综述期刊。。。2022.12月投稿，2023.4月大修，2023.5中旬修回后一周接受并online。前期找审稿人花费了不少时间，后面进行的非常快！点赞👍祝期刊越来越好～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Fri Jun 02 09:44:23 CST 2023, time=2023-06-02, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2110794, encodeId=d86f2110e9401, content=Underreview 快俩月了，Status date变化好几次了是啥意思呢？？？？有投过的老哥交流一下嘛？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Jan 18 22:47:43 CST 2023, time=2023-01-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2198821, encodeId=cd84219882131, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：药理 经验分享：困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25d46161544, createdName=ms2000001453861010, createdTime=Tue Apr 16 15:26:25 CST 2024, time=2024-04-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176210, encodeId=dee821e62105f, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：首次决定时间很长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13586411720, createdName=ms4000000644047431, createdTime=Thu Dec 21 00:04:24 CST 2023, time=2023-12-21, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1096295, encodeId=e71e10962954a, content=我为什么投了一个月/很长时间都没有消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974654, encodeId=b3749e4654ff, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：目前该杂志需要接受约稿，自己投不行的，本人通过约稿于2020年4月接受了一篇，前后花费大半年时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a24f4cfbb98ea468e1e28fabfa0347c5.jpg, createdBy=92c81626055, createdName=xinshihaoran, createdTime=Fri Jun 18 14:24:44 CST 2021, time=2021-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241093, encodeId=2d121241093a4, content=审稿周期多久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e7a5327063, createdName=148bf3b8m15暂无昵称, createdTime=Fri Aug 26 09:29:34 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096296, encodeId=96b8109629693, content=期刊的审稿时间一般是多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553240, encodeId=4856553240fc, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：杂志学术水平较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=570, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1de937989, createdName=z8160720, createdTime=Sat Mar 03 18:10:00 CST 2018, time=2018-03-03, status=1, ipAttribution=)]

2021-12-28 桑晒麦拉

期刊的审稿时间一般是多久？

263 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=959640, encodeId=3fa195964008, content=先给编辑写询问信，编辑同意投稿发出约稿申请，给一个月时间写作，然后2月28日投出去，一个月左右给初审意见大修，然后痛苦修改一个月后，4月21日投出去，4月22日直接编辑接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0fda5217760, createdName=14772c6cm60暂无昵称, createdTime=Fri Apr 23 00:27:32 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140450, encodeId=f718214045047, content=审稿速度:3.0 经验分享：话说这是药学的顶级综述期刊。。。2022.12月投稿，2023.4月大修，2023.5中旬修回后一周接受并online。前期找审稿人花费了不少时间，后面进行的非常快！点赞👍祝期刊越来越好～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Fri Jun 02 09:44:23 CST 2023, time=2023-06-02, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2110794, encodeId=d86f2110e9401, content=Underreview 快俩月了，Status date变化好几次了是啥意思呢？？？？有投过的老哥交流一下嘛？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Jan 18 22:47:43 CST 2023, time=2023-01-18, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2198821, encodeId=cd84219882131, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：药理 经验分享：困难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25d46161544, createdName=ms2000001453861010, createdTime=Tue Apr 16 15:26:25 CST 2024, time=2024-04-16, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176210, encodeId=dee821e62105f, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：首次决定时间很长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13586411720, createdName=ms4000000644047431, createdTime=Thu Dec 21 00:04:24 CST 2023, time=2023-12-21, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1096295, encodeId=e71e10962954a, content=我为什么投了一个月/很长时间都没有消息？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=314, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974654, encodeId=b3749e4654ff, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：目前该杂志需要接受约稿，自己投不行的，本人通过约稿于2020年4月接受了一篇，前后花费大半年时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a24f4cfbb98ea468e1e28fabfa0347c5.jpg, createdBy=92c81626055, createdName=xinshihaoran, createdTime=Fri Jun 18 14:24:44 CST 2021, time=2021-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241093, encodeId=2d121241093a4, content=审稿周期多久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e7a5327063, createdName=148bf3b8m15暂无昵称, createdTime=Fri Aug 26 09:29:34 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096296, encodeId=96b8109629693, content=期刊的审稿时间一般是多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553240, encodeId=4856553240fc, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：杂志学术水平较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=570, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1de937989, createdName=z8160720, createdTime=Sat Mar 03 18:10:00 CST 2018, time=2018-03-03, status=1, ipAttribution=)]

2018-03-03 z8160720

审稿速度:12.0 | 投稿命中率:25.0
经验分享：杂志学术水平较高

570 0 举报

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务